Neubauer A S, Hoops J P
Augenklinik der Ludwig-Maximilians-Universität, Mathildenstr. 8, 80336 München.
Klin Monbl Augenheilkd. 2000 Nov;217(5):308-11. doi: 10.1055/s-2000-10374.
Interferon associated retinopathy has been described mainly by Japanese working groups as a complication of systemic interferon therapy for various diseases. In Europe, only few reports exist, especially regarding interferon therapy for dermal malignant melanoma.
We report a 58-year-old female patient with symptomatic, bilateral microangiopathy caused by interferon for metastatic dermal malignant melanoma. Multiple bilateral cotton wool spots caused visual field defects and unilateral decreased visual acuity. The retinal changes were reversible when stopping interferon therapy.
Interferon-associated microangiopathy occurs as a complication of interferon therapy independently of the treated systemic disease. Rarely, retinopathy becomes symptomatic as reported in this case. Symptoms were fully, clinical signs were partially reversible. A regular ophthalmologic monitoring of all patients receiving interferon therapy is recommended. Monitoring aims to detecting vision-threatening retinal changes in a reversible phase.
干扰素相关性视网膜病变主要由日本研究团队描述为各种疾病全身应用干扰素治疗的一种并发症。在欧洲,相关报道较少,尤其是关于皮肤恶性黑色素瘤的干扰素治疗。
我们报告一名58岁女性患者,因转移性皮肤恶性黑色素瘤接受干扰素治疗而出现有症状的双侧微血管病变。双侧多个棉絮斑导致视野缺损和单眼视力下降。停用干扰素治疗后视网膜病变可逆转。
干扰素相关性微血管病变作为干扰素治疗的并发症出现,与所治疗的全身性疾病无关。如本病例报道,视网膜病变很少出现症状。症状完全缓解,临床体征部分可逆。建议对所有接受干扰素治疗的患者进行定期眼科监测。监测旨在发现处于可逆阶段的威胁视力的视网膜病变。